首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >A Preliminary Study of the Microbial Resources and Their Biological Activities of the East China Sea
【2h】

A Preliminary Study of the Microbial Resources and Their Biological Activities of the East China Sea

机译:东海地区微生物资源及其生物活性的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

East China Sea is one of the four sea areas in China, which possesses peculiar ecological environment and many kinds of living creatures, especially the microorganisms. We established the East China Sea microorganism library (during 2006–2010) for the first time, which stored about 30000 strains that covered most kinds of the species. In this paper, 395 pure strains of East China Sea microorganism library which belong to 33 different genera were mainly introduced. Sulfitobacter, Halomonas, Bacillus, Pseudoalteromonas, and Idiomarina were the most dominant species. On the large-scale biological activity screening of the 395 strains, 100 strains possess different biological activities based on different screening models, of which 11.4% strains have antibacterial activities, 15.9% have cytotoxicity activities, and 6.1% have antioxidation activities. Besides, the secondary metabolites of 6 strains with strong biological activities were studied systematically; diketopiperazines and macrocyclic lactones are the active secondary metabolites. The species and the biological activity of microorganisms diversity, the abundant structure type of the secondary metabolites, and their bioactivities all indicate that East China Sea is a potent marine microorganisms-derived developing resource for drug discovery.
机译:东海是中国四大海域之一,拥有独特的生态环境和多种生物,尤其是微生物。我们首次建立了东海微生物库(2006-2010年),其中存储了约30000株涵盖大多数物种的菌株。本文主要介绍了隶属于33个不同属的395株纯东海微生物库。最重要的种类是枯萎杆菌,盐单胞菌,芽孢杆菌,假单胞菌和异狄氏剂。在395株菌株的大规模生物活性筛选中,根据不同的筛选模型,有100株菌株具有不同的生物学活性,其中11.4%的菌株具有抗菌活性,15.9%的菌株具有细胞毒性活性,6.1%的菌株具有抗氧化活性。此外,系统地研究了6个具有较强生物活性的菌株的次生代谢产物。二酮哌嗪和大环内酯是活性次生代谢产物。微生物的种类和生物活性,次生代谢产物的丰富结构类型及其生物活性均表明东海是海洋微生物衍生的强大药物开发资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号